Pharmaceutical Supplies Procurement for Indian Army Healthcare

This tender, identified by Bid Number GEM/2026/B/8020019, is issued by the Department of Military Affairs, under the Ministry of Defence, for the Indian Army. The procurement, which concludes on October 10, 2026, at 12:00 PM, encompasses a comprehensive list of pharmaceutical supplies totaling 56,431 units. Key items include Hepatitis A live Vaccine, various injectable analgesics and anesthetics such as Ketamine HCl, Fentanyl Citrate, Morphine, Pethedine, and Midazolam, alongside essential medications for pain management like Mefenemic Acid and Ibuprofen Syrup. The tender also specifies antiepileptic drugs including Diazepam, Phenobarbitone Sodium, Fosphenytoin, and Sodium Valproate, as well as treatments for parasitic infections (Diethylcarbamazine) and chronic conditions like Parkinson's disease (Levodopa plus Carbidopa), hypertension (Clinidipine), and Hepatitis B (Tenofovir, Entecavir). Further requirements include medications for nausea and vomiting (Doxylamine Succinate plus Pyridoxine Hydrochloride), electrolytic balance (Magnesium Sulphate), respiratory conditions (Desmopressin Nasal spray), Vitamin B12, diabetes management (Dapagliflozin), pain relief (Capsacain Gel), anti-inflammatory agents (Methyl Prednisolone Sodium Succinate), enzymes (Serratiopeptidase), and antipsychotic treatments (Paliperidone in multiple dosages). The procurement is dated September 19, 2026, with a bid start date of October 9, 2026, at 12:00 PM, and is managed through the office located in Patna.